PharmaTimes | Nachrichten

❌

Mehr »

Montag, 24.09.2018 Börsentäglich über 12.000 News von 597 internationalen Medien

Indizes	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage

Aktien	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage

Xetra-Orderbuch

Devisen	Kurs	%

Rohstoffe	Kurs	%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)

Aufklappen

Schliessen

Zeit	Aktuelle Nachrichten
Fr	Medical & Scientific Excellence Awards - Have you entered yet?
Fr	2018 PM Society Digital Awards winners announced
Fr	ABPI enters five-year partnership with AHSN
Fr	Celgene walks away from Oncomed's navicixizumab
Fr	Daiichi to test cancer drug combo
Do	Domainex appoints Dr Trevor Perrior as CEO
Do	CR UK forms £30m partnership with EU cancer charities
Do	Setback for Pharming's bid to expand use of Ruconest
Do	EU green light for new Humira biosimilar
Do	Astellas' kidney disease drug shows promise in PhIII
Do	Addex joins UK drug and brain research initiative
Mi	Norgine buys rights to sell Shield's iron deficiency therapy
Mi	NICE rejects Novartis' CAR-T Kymriah for adult lymphoma
Mi	AI drug discovery platform gets £1m innovation boost
Mi	The number of children being vaccinated in England falls again
Mi	Almirall steps into psoriasis market with Ilumetri approval
Mi	Actelion's Opsumit shows promise in portopulmonary hypertension
Di	Allergan, Sosei suspend clinical development of dementia drug
Di	AstraZeneca' Fasenra shows long-term efficacy in eosinophilic asthma
Di	CR UK invests £14m in London cancer biotherapeutics hub
Di	Innovate UK gives £1 million to AI project
Di	New study to explore genetic links to depression and anxiety
17.09.	Allergan snaps up Bonti
17.09.	NICE nod for Novartis' targeted skin cancer combo
17.09.	Teva's anti-CGRP drug Ajvoy cleared for migraine prevention

Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und mit der Push-Technologie von

Aktuelle News von PharmaTimes